Organovo » Healthcare 3D Printing Bioprinting Directory

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

 

Organization Name
Categories
Headquater location
Description

Organovo

Organovo Holdings, Inc., (NASDAQ: ONVO) is a biotech platform company that has developed a leadership position with its revolutionary ability to 3D bioprint tissues with human functionality.

Headquarters 6275 Nancy Ridge Drive San Diego CA 92121 United States
  • blank
  • blank
Categories: Bioprinting
CEO: Taylor Crouch CEO and President Phone: +1 (858) 224-1000
Links:

Details

Organovo Holdings, Inc., (NASDAQ: ONVO) is a biotech platform company that has developed a leadership position with its revolutionary ability to 3D bioprint tissues with human functionality. The Company is pursuing multiple IND-track programs to develop its NovoTissues® to address a number of serious unmet medical needs in adult and pediatric populations, initially focusing on liver disease. Organovo’s first IND-track program for Alpha-1-antitrypsin deficiency recently received orphan drug designation from the FDA, and the Company expects to file its first IND in 2020. In order to help fund its plan to initiate multiple IND-track programs, the Company is providing access to its ExVive™ in vitro tissue disease modeling platform to facilitate high value drug discovery and development collaborations. Organovo’s wholly-owned subsidiary, Samsara Sciences, provides the Company and its clients with high quality human liver and kidney cells for research applications. Organovo is changing the shape of life science research and transforming medical care. Learn more at http://www.organovo.com.